# Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines

> **NCT00776438** · PHASE2 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 160 (actual)

## Conditions studied

- Influenza
- Orthomyxovirus Infections
- Myxovirus Infection

## Interventions

- **BIOLOGICAL:** Inactivated, split-virion, influenza vaccine
- **BIOLOGICAL:** Inactivated, split-virion, influenza vaccine
- **BIOLOGICAL:** Inactivated, split-virion influenza vaccine
- **BIOLOGICAL:** Inactivated, split-virion influenza vaccine

## Key facts

- **NCT ID:** NCT00776438
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2009-02
- **Final completion:** 2009-04
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2015-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00776438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00776438, "Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00776438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*